Vaidya Sane Ayurved Laboratories Limited — Updates, 09-12-2025: General Updates
09-12-2025 | 04:53 pm
09-12-2025 | 04:53 pm
Madhavbaug detailed the utilization of 73.20 Cr from its preferential warrant issue. Funds are earmarked for 15 Cr working capital, 13.20 Cr for general corporate purposes, and 45 Cr for CAPEX including a new hospital at Kondhali and medical equipment.
No comments yet. Be the first to comment!
All announcements from Vaidya Sane Ayurved Laboratories Limited
